Pathway-Specific Dopamine Abnormalities in Schizophrenia
2016 · Biological Psychiatry · 293 citations
https://doi.org/10.1016/j.biopsych.2016.03.2104
L
Lawrence S. Kegeles
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
166
Papers
12.5K
Citations
58
h-index
100
i10-index
Lawrence S. Kegeles is an academic researcher from Columbia University Irving Medical Center. The author has contributed to research in topics: Neurotransmitter Receptor Influence on Behavior & Neuroscience and Neuropharmacology Research & Functional Brain Connectivity Studies. The author has an h-index of 58, co-authored 142 publications.
ORCID: 0000-0002-8083-1167Papers by this author
worksGABA level, gamma oscillation, and working memory performance in schizophrenia
2014 · NeuroImage Clinical · 188 citations
https://doi.org/10.1016/j.nicl.2014.03.007
A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder
2015 · Molecular Psychiatry · 140 citations
https://doi.org/10.1038/mp.2015.83
Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression
2001 · Biological Psychiatry · 132 citations
https://doi.org/10.1016/s0006-3223(01)01089-7
Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder
2021 · Translational Psychiatry · 97 citations
https://doi.org/10.1038/s41398-021-01541-1
NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humans
2001 · Synapse · 92 citations
https://doi.org/10.1002/syn.10010
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat